Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Covington
AstraZeneca
Boehringer Ingelheim
Julphar
Healthtrust
Express Scripts
Mallinckrodt
Chinese Patent Office

Generated: May 25, 2018

DrugPatentWatch Database Preview

Formulation information for generic ingredient: selegiline hydrochloride

« Back to Dashboard

SELEGILINE HYDROCHLORIDE

CASRN: 14611-52-0UNII:

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Healthtrust
Citi
Baxter
Harvard Business School
Johnson and Johnson
Medtronic
Mallinckrodt
Teva